Lupus & antiphospholipid syndrome
Impact of telemedicine on disease activity assessment: A case-crossover study nested within a cohort of patients with systemic lupus erythematosus
Main finding · SLEDAI-2K scoreResult — go to the resultMean difference −1.641 95% CI −2.773 to −0.510Authors' conclusion
We found that telemedicine assessment was associated with a much higher disease activity score than subsequent assessments, which may suggest an overestimation of disease activity and later assessment accuracy.
Study context
- Population
- Patients with systemic lupus erythematosus (SLE) fulfilling SLICC classification criteria, March 2020–March 2021, Saudi Arabia (88% female; mean age 36 [SD 13] years)
- Participants
- 92 patients
- Exposure
- Telemedicine assessment vs in-person follow-up assessments
- Telemedicinen = 92reference
- Follow-up visitsn = 92
- Outcome
- Difference in SLEDAI-2K score
Methodological detailsnational prospective cohort, repeated measure model, adjusted for demographics, medications and changes in steroid doses, sensitivity analyses
- National prospective cohort
- Repeated measure model
- Adjusted for demographics, medications and changes in steroid doses
- Sensitivity analyses
Main finding
SLEDAI-2K score
Mean difference
−1.641
95% CI −2.773 to −0.510
P = 0.005*
Follow-up visitsvs Telemedicine
mean difference −1.641 (95% CI −2.773 to −0.510); P = 0.005*
As reported in the abstract
Observational data: associations, not effects.
Further findings
- Results consistent in all sensitivity analyses
Original publication
Impact of telemedicine on disease activity assessment: A case-crossover study nested within a cohort of patients with systemic lupus erythematosus. Lupus. Published 3 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →